First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution.
Autor: | Jonker DM, Koch M, Larsson P, Ravi A, Buur Rasmussen B, Speer R, Mannaerts B |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2021 Dec; Vol. 59 (12), pp. 794-803. |
DOI: | 10.5414/CP204040 |
Abstrakt: | Objective: To determine whether serum human follicle-stimulating hormone (FSH) levels after single subcutaneous dosing of highly purified human menopausal gonadotropins (HP-hMG) in a liquid formulation and a powder formulation are bioequivalent. Materials and Methods: This was a randomized, two-way, crossover, single-dose, bioequivalence trial comparing Menopur liquid injected by pre-filled pen, with Menopur powder injected by conventional syringe and needle. The primary endpoints were AUC Results: In total, 76 women were randomized, and 56 completed the trial. The mean FSH and hCG serum concentration-time profiles were comparable between the two HP-hMG formulations. The geometric mean ratios and 90% confidence intervals of FSH for HP-hMG liquid versus HP-hMG powder were 1.12 (1.0562 - 1.1889) for AUC Conclusion: The 90% CIs for the geometric mean ratios of serum FSH AUC |
Databáze: | MEDLINE |
Externí odkaz: |